These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38287246)

  • 1. Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study.
    Zhao H; Feng A; Luo D; Yuan T; Lin YF; Ling X; Zhong H; Li J; Li L; Zou H
    BMC Infect Dis; 2024 Jan; 24(1):138. PubMed ID: 38287246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
    van Griensven J; Phirum L; Choun K; Thai S; De Weggheleire A; Lynen L
    PLoS One; 2014; 9(2):e88552. PubMed ID: 24533106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistently low CD4 cell counts are associated with hepatic events in HCV/HIV coinfected patients: data from the national free antiretroviral treatment program of China.
    Lin W; Zhong H; Wen C; He Y; Zheng X; Li H; Chen X; He H; Chen J; Chen L; Liu C; Tang X; Cai W; Li L
    Chin Med J (Engl); 2022 Nov; 135(22):2699-2705. PubMed ID: 36574222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In HIV-Infected Immunological Non-Responders, Hepatitis C Virus Eradication Contributes to Incomplete Normalization of Systemic Inflammation Indexes, but Does Not Lead to Rapid CD4+ T-Cell Count Recovery.
    Saidakova EV; Korolevskaya LB; Shmagel NG; Vlasova VV; Shardina KY; Chereshnev VA; Shmagel KV
    Dokl Biochem Biophys; 2023 Oct; 512(1):274-278. PubMed ID: 38093130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients.
    Portocarrero Nuñez JA; Gonzalez-Garcia J; Berenguer J; Gallego MJV; Loyarte JAI; Metola L; Bernal E; Navarro G; Del Amo J; Jarrín I;
    Medicine (Baltimore); 2018 Sep; 97(38):e12238. PubMed ID: 30235668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased early activation of CD56dimCD16dim/- natural killer cells in immunological non-responders correlates with CD4+ T-cell recovery.
    Zhang QY; Zhang X; Su B; Liu LF; Yang XD; Tang B; Xia H; Ma P; Zhang T; Wu H
    Chin Med J (Engl); 2020 Nov; 133(24):2928-2939. PubMed ID: 33252378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.
    Hua L; Andersen JW; Daar ES; Glesby MJ; Hollabaugh K; Tierney C
    AIDS; 2013 Nov; 27(17):2725-34. PubMed ID: 23921611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study.
    Engsig FN; Gerstoft J; Kronborg G; Larsen CS; Pedersen G; Røge B; Jensen J; Nielsen LN; Obel N
    BMC Infect Dis; 2010 Nov; 10():318. PubMed ID: 21044307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
    Taye S; Lakew M
    BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between CD4
    Lu D; Zhang JB; Wang YX; Geng ST; Zhang Z; Xu Y; Li SY; Wang KH; Kuang YQ
    BMC Infect Dis; 2021 Aug; 21(1):742. PubMed ID: 34344350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa.
    Martin NK; Devine A; Eaton JW; Miners A; Hallett TB; Foster GR; Dore GJ; Easterbrook PJ; Legood R; Vickerman P
    AIDS; 2014 Jan; 28 Suppl 1():S35-46. PubMed ID: 24468945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.
    Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
    AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
    Martinez V; Ta TD; Mokhtari Z; Guiguet M; Miailhes P; Valantin MA; Charlotte F; Bertheau P; Molina JM; Katlama C; Caumes E
    BMC Res Notes; 2012 Jul; 5():180. PubMed ID: 22490728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of suboptimal immune recovery among a Chinese Yi ethnicity population with sustained HIV suppression.
    Chen L; Liu CH; Kang S; Du L; Ma F; Li C; Bai L; Li H; Tang H
    BMC Infect Dis; 2022 Feb; 22(1):137. PubMed ID: 35135485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence and effect of HBV and HCV co-infections on the immuno-virologic responses of adult HIV-infected persons on anti-retroviral therapy.
    Annison L; Hackman H; Eshun PF; Annison S; Forson P; Antwi-Baffour S
    PLoS One; 2022; 17(11):e0278037. PubMed ID: 36417469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.